Immunotherapy in Renal Cell Carcinoma: The Future Is Now
Sign Up to like & getrecommendations! Published in 2020 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms21072532
Abstract: Renal cell carcinoma is the third type of urologic cancer and has a poor prognosis with 30% of metastatic patients at diagnosis. The antiangiogenics and targeted immunotherapies led to treatment remodeling emphasizing the role of… read more here.
Keywords: carcinoma future; cell carcinoma; renal cell; immunotherapy renal ... See more keywords